Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Jul 6, 2020
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2020-07-02$4.82/sh−94$453→ 17,845 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 07/01/2020.